AMYLIN-ANALOGA
European patent · EP3046573 · Deleted
Register entry
- Publication number
- EP3046573
- Application number
- EP14776835
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Sep 19, 2014
- Published
- Jul 27, 2016
- Granted
- Dec 12, 2018
- Deleted
- Sep 30, 2019
- Reason
- Annual fee unpaid
- IPC classes
- A61K 38/22 (2006.01)C07K 14/575 (2006.01)A61K 38/26 (2006.01)A61K 38/28 (2006.01)A61K 47/54 (2017.01)
- Priority
- DK 201300536 19.09.2013DK 201400253 09.05.2014
- PCT application
- PCT/EP2014/070037 19.09.2014
- PCT publication
- WO2015/040182 26.03.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 20, 2020
Deleted, fee unpaid
Published in Swissreg on 20.05.2020
- Oct 9, 2019
Owner
- Owner
- Zealand Pharma A/S, Smedeland 36, 2600 Glostrup, Denmark → Zealand Pharma A/S, Sydmarken 11, 2860 Søborg, Denmark
Published in Swissreg on 09.10.2019
- Dec 19, 2018
Granted
Published in Swissreg on 19.12.2018
Parties
Inventor
JUST, Rasmus
2200 København N, DK
DEMMER, Oliver
DK-2400 København NV, DK
GIEHM, Lise
2000 Frederikberg, DK
MATHIESEN, Jesper Mosolff
3520 Farum, DK
SKARBALIENE, Jolanta
2690 Karlsunde, DK
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.